Clostridioides difficile Infections: Prevention and Treatment Strategies.
Study Design
- Loại nghiên cứu
- Review
- Đối tượng nghiên cứu
- Patients with C. difficile infection
- Can thiệp
- Clostridioides difficile Infections: Prevention and Treatment Strategies. None
- Đối chứng
- None
- Kết quả chính
- C. difficile infection treatment outcomes
- Xu hướng hiệu quả
- Positive
- Nguy cơ sai lệch
- Unclear
Abstract
Clostridioides difficile is the most common causative agent of antibiotic-associated diarrhea. This spore forming, obligate anaerobic, gram-positive bacillus is becoming responsible for an increasing number of infections worldwide, both in community and in hospital settings, whose severity can vary widely from an asymptomatic infection to a lethal disease. While discontinuation of antimicrobial agents and antibiotic treatment of the infection remain the cornerstone of therapy, more recent fecal microbiota transplantation has also been valid as a therapy. The use of probiotics, especially Saccharomyces boulardii CNCM I-745 have become valid forms of prevention therapy. Although there are studies in adults with microbiota-targeted new generation therapies and Clostridium difficile vaccines, there are no data in the paediatric age group yet.
Tóm lược
The use of probiotics, especially Saccharomyces boulardii CNCM I-745 have become valid forms of prevention therapy and there are no data in the paediatric age group yet.
Used In Evidence Reviews
Similar Papers
The American journal of gastroenterology · 2006
Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.
The American journal of clinical nutrition · 2001
Protection from gastrointestinal diseases with the use of probiotics.
Advances in biochemical engineering/biotechnology · 2008
Probiotics, prebiotics, and synbiotics.
World journal of gastroenterology · 2010
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.
Frontiers in medicine · 2018
Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.
Journal of clinical gastroenterology · 2011